Allen Lefkowitz
Direktor/Vorstandsmitglied bei Cycle Pharmaceuticals Ltd.
Aktive Positionen von Allen Lefkowitz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Cycle Pharmaceuticals Ltd.
 Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Direktor/Vorstandsmitglied | 01.11.2013 | - |
Karriereverlauf von Allen Lefkowitz
Statistik
International
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Cycle Pharmaceuticals Ltd.
Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Health Technology |
- Börse
- Insiders
- Allen Lefkowitz
- Erfahrung
